🔎 Trials Near Me

Akèy › Limfòm Non-Hodgkin › New Jersey

Etid klinik pou Limfòm Non-Hodgkin nan New Jersey

13 etid pou Limfòm Non-Hodgkin ap chèche patisipan nan sit nan New Jersey.

Vil nan New Jersey

Tèks ofisyèl etid la (Anglè)

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Astera Cancer Care ( Site 2732), East Brunswick
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

  • Clinical Trial Site, New Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07249528

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Hackensack, Hackensack
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Hackensack University Medical Center, Hackensack
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

SynKIR-310 for Relapsed/Refractory B-NHL

  • Rutgers Cancer Institute, New Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Englewood Hospital and Medical Center, Englewood
  • CentraState Medical Center, Freehold
  • Hackettstown Medical Center, Hackettstown
  • ak 5 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Regional Cancer Care Associates, Hackensack
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

  • Hackensack University Medical Center, Hackensack
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 22, 2025 · NCT02848274

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

  • Hackensack University Medical Center, Hackensack
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 20, 2024 · NCT05967416

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.